Colitis Latest Advances

Maternal Exposure to Bisphenol A Bis(diphenyl Phosphate) Induces Offspring Colitis through Disrupting the Gut Microbiome-Metabolite Axis.

Journal: Environmental science & technology

Published: April 15, 2026

The predictive value of intestinal ultrasound for treatment response in inflammatory bowel disease: a systematic review and pooled data analysis.

Journal: Journal of Crohn's & colitis

Published: April 15, 2026

Real-world patient characteristics, treatments, and outcomes during and after severe ulcerative colitis hospitalization.

Journal: Journal of Crohn's & colitis

Published: April 14, 2026

Ophiopogon japonicus Polysaccharides Promote Microbial Production Of Chenodeoxycholic Acid To Alleviate Ulcerative Colitis in Mice by Inhibiting the STING1-Related NF-κB Pathway.

Journal: Journal of agricultural and food chemistry

Published: April 14, 2026

Correction to: Association between inflammatory bowel disease, current therapies, and cardiovascular events: a review and meta-analysis of data from 2.2 million individuals.

Journal: Journal of Crohn's & colitis

Published: April 14, 2026

Advances in clinical management of acute severe ulcerative colitis

Journal: Zhejiang da xue xue bao. Yi xue ban = Journal of Zhejiang University. Medical sciences

Published: April 13, 2026

Mapping adaptive immune responses toward fungal antigens in inflammatory bowel disease using T cell repertoire sequencing and phage-immunoprecipitation sequencing.

Journal: Journal of Crohn's & colitis

Published: April 13, 2026

AI technologies: transforming global IBD care?

Journal: Journal of Crohn's & colitis

Published: April 11, 2026

Correction to: DOP055 Efficacy and Safety Up to 3 Years of Risankizumab Maintenance Treatment in Patients With Moderately to Severely Active Ulcerative Colitis: Interim Results from Phase 3 COMMAND Open-Label Extension Study.

Journal: Journal of Crohn's & colitis

Published: April 11, 2026

Assessing the impact of delivery method on severe maternal morbidity among individuals with inflammatory bowel disease: a population-based study.

Journal: Journal of Crohn's & colitis

Published: April 11, 2026

Difficile to treat: advanced management strategies in difficult to treat clostridioides difficile infections.

Journal: Expert review of anti-infective therapy

Published: April 11, 2026

10-Hydroxy-2-decenoic Acid Attenuates Colitis-Associated Cognitive Dysfunction via IFITM3-Related Gut-Brain Axis Inflammation.

Journal: Journal of agricultural and food chemistry

Published: April 10, 2026

Colitis Latest Advances

Find the Latest Research About Colitis

Maternal Exposure to Bisphenol A Bis(diphenyl Phosphate) Induces Offspring Colitis through Disrupting the Gut Microbiome-Metabolite Axis.

Maternal Exposure to Bisphenol A Bis(diphenyl Phosphate) Induces Offspring Colitis through Disrupting the Gut Microbiome-Metabolite Axis.

The predictive value of intestinal ultrasound for treatment response in inflammatory bowel disease: a systematic review and pooled data analysis.

The predictive value of intestinal ultrasound for treatment response in inflammatory bowel disease: a systematic review and pooled data analysis.

Real-world patient characteristics, treatments, and outcomes during and after severe ulcerative colitis hospitalization.

Real-world patient characteristics, treatments, and outcomes during and after severe ulcerative colitis hospitalization.

Ophiopogon japonicus Polysaccharides Promote Microbial Production Of Chenodeoxycholic Acid To Alleviate Ulcerative Colitis in Mice by Inhibiting the STING1-Related NF-κB Pathway.

Ophiopogon japonicus Polysaccharides Promote Microbial Production Of Chenodeoxycholic Acid To Alleviate Ulcerative Colitis in Mice by Inhibiting the STING1-Related NF-κB Pathway.

Correction to: Association between inflammatory bowel disease, current therapies, and cardiovascular events: a review and meta-analysis of data from 2.2 million individuals.

Correction to: Association between inflammatory bowel disease, current therapies, and cardiovascular events: a review and meta-analysis of data from 2.2 million individuals.

Advances in clinical management of acute severe ulcerative colitis

Advances in clinical management of acute severe ulcerative colitis

Mapping adaptive immune responses toward fungal antigens in inflammatory bowel disease using T cell repertoire sequencing and phage-immunoprecipitation sequencing.

Mapping adaptive immune responses toward fungal antigens in inflammatory bowel disease using T cell repertoire sequencing and phage-immunoprecipitation sequencing.

AI technologies: transforming global IBD care?

AI technologies: transforming global IBD care?

Correction to: DOP055 Efficacy and Safety Up to 3 Years of Risankizumab Maintenance Treatment in Patients With Moderately to Severely Active Ulcerative Colitis: Interim Results from Phase 3 COMMAND Open-Label Extension Study.

Correction to: DOP055 Efficacy and Safety Up to 3 Years of Risankizumab Maintenance Treatment in Patients With Moderately to Severely Active Ulcerative Colitis: Interim Results from Phase 3 COMMAND Open-Label Extension Study.

Assessing the impact of delivery method on severe maternal morbidity among individuals with inflammatory bowel disease: a population-based study.

Assessing the impact of delivery method on severe maternal morbidity among individuals with inflammatory bowel disease: a population-based study.

Difficile to treat: advanced management strategies in difficult to treat clostridioides difficile infections.

Difficile to treat: advanced management strategies in difficult to treat clostridioides difficile infections.

10-Hydroxy-2-decenoic Acid Attenuates Colitis-Associated Cognitive Dysfunction via IFITM3-Related Gut-Brain Axis Inflammation.

10-Hydroxy-2-decenoic Acid Attenuates Colitis-Associated Cognitive Dysfunction via IFITM3-Related Gut-Brain Axis Inflammation.